Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10048832HBVENSG00000101000.6protein_codingPROCRNoNo10544Q9UNN8
TVIS10048833HBVENSG00000101000.6protein_codingPROCRNoNo10544Q9UNN8
TVIS20008217HPVENSG00000101000.6protein_codingPROCRNoNo10544Q9UNN8
TVIS20009595HPVENSG00000101000.6protein_codingPROCRNoNo10544Q9UNN8
TCGA Plot Options
Drug Information
GenePROCR
DrugBank IDDB00055
Drug NameDrotrecogin alfa
Target IDBE0001161
UniProt IDQ9UNN8
Regulation Type
PubMed IDs9529319; 12871285; 12353077; 17566522; 15118520
CitationsFukudome K, Ye X, Tsuneyoshi N, Tokunaga O, Sugawara K, Mizokami H, Kimoto M: Activation mechanism of anticoagulant protein C in large blood vessels involving the endothelial cell protein C receptor. J Exp Med. 1998 Apr 6;187(7):1029-35.@@Ruf W, Dorfleutner A, Riewald M: Specificity of coagulation factor signaling. J Thromb Haemost. 2003 Jul;1(7):1495-503.@@Castellino FJ, Liang Z, Volkir SP, Haalboom E, Martin JA, Sandoval-Cooper MJ, Rosen ED: Mice with a severe deficiency of the endothelial protein C receptor gene develop, survive, and reproduce normally, and do not present with enhanced arterial thrombosis after challenge. Thromb Haemost. 2002 Sep;88(3):462-72.@@Cerchiara E, Tirindelli MC, Giannetti B, Dicuonzo G, Avvisati G: [The numerous properties of the anticoagulant protein C]. Clin Ter. 2007 Mar-Apr;158(2):181-7.@@Liaw PC: Endogenous protein C activation in patients with severe sepsis. Crit Care Med. 2004 May;32(5 Suppl):S214-8.
GroupsApproved; Investigational; Withdrawn
Direct ClassificationPeptides
SMILES
Pathways
PharmGKBPA131548935
ChEMBL